Literature DB >> 31776848

Hsa_circ_0046159 is involved in the development of chronic thromboembolic pulmonary hypertension.

Ran Miao1,2, Juanni Gong3, Chunyang Zhang1, Ying Wang4, Xiaojuan Guo5, Jifeng Li3, Suqiao Yang3, Tuguang Kuang3, Jiuchang Zhong6, Huasong Feng7.   

Abstract

The present study was performed to screen for potential molecular biomarkers and to assess the underlying mechanisms of chronic thromboembolic pulmonary hypertension (CTEPH) by using sequencing data analysis of microRNAs (miRNAs) and circular RNAs (circRNAs). Total RNA was isolated from peripheral-blood samples from five CTEPH patients and from five normal individuals. Based upon the identification of differentially expressed miRNAs (Affymetrix miRNA chip) and circRNAs (Agilent circRNA chip), target predictions for these differentially expressed miRNAs and functional enrichment analyses of the miRNAs and circRNAs were performed. Subsequently, the miRNA partner predictions of these differentially expressed circRNAs and co-expression analyses of differentially expressed circRNAs and miRNAs were conducted. Based on the results of these analyses, a competing endogenous RNA (ceRNA) network was constructed. Finally, the expression of circRNAs was detected by quantitative real-time PCR (qRT-PCR). Within the miRNA-circRNA regulatory network, hsa_circ_0026480 and hsa_circ_0046159 were predicted to interact with miR-27a-3p and miR-1226-3p, respectively with greater degree. Specially, ATP2A2-that had a ceRNA relationship with hsa_circ_0046159-was predicted as a target of miR-1226-3p. The results of RT-PCR also revealed a significantly increased expression of hsa_circ_0046159 in CTEPH samples than that in normal samples.

Entities:  

Keywords:  Chronic thromboembolic pulmonary hypertension; Circular RNA; Competing endogenous RNA; Differential expression analysis; microRNA

Year:  2020        PMID: 31776848     DOI: 10.1007/s11239-019-01998-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Profiling and bioinformatics analyses reveal differential circular RNA expression in hypertensive patients.

Authors:  Na Wu; Ling Jin; Jun Cai
Journal:  Clin Exp Hypertens       Date:  2017-05-23       Impact factor: 1.749

3.  Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.

Authors:  Christin E Burd; William R Jeck; Yan Liu; Hanna K Sanoff; Zefeng Wang; Norman E Sharpless
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

4.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

5.  Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.

Authors:  M Sean McMurtry; Sebastien Bonnet; Xichen Wu; Jason R B Dyck; Alois Haromy; Kyoko Hashimoto; Evangelos D Michelakis
Journal:  Circ Res       Date:  2004-09-16       Impact factor: 17.367

6.  MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.

Authors:  Huachun Cui; Sami Banerjee; Na Xie; Jing Ge; Rui-Ming Liu; Sadis Matalon; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

7.  Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension.

Authors:  Shin Watanabe; Kiyotake Ishikawa; Maria Plataki; Olympia Bikou; Erik Kohlbrenner; Jaume Aguero; Lahouaria Hadri; Iratxe Zarragoikoetxea; Kenneth Fish; Jane A Leopold; Roger J Hajjar
Journal:  Pulm Circ       Date:  2018-08-21       Impact factor: 3.017

8.  Modelling Competing Endogenous RNA Networks.

Authors:  Carla Bosia; Andrea Pagnani; Riccardo Zecchina
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

9.  Circular RNAs function as competing endogenous RNAs in multiple types of cancer.

Authors:  Qing Ji; Chengcheng Zhang; Xiaoting Sun; Qi Li
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

10.  The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.

Authors:  Syed Rehan Quadery; Andrew J Swift; Catherine G Billings; Alfred A R Thompson; Charles A Elliot; Judith Hurdman; Athanasios Charalampopoulos; Ian Sabroe; Iain J Armstrong; Neil Hamilton; Paul Sephton; Sian Garrad; Joanna Pepke-Zaba; David P Jenkins; Nicholas Screaton; Alexander M Rothman; Allan Lawrie; Trevor Cleveland; Steven Thomas; Smitha Rajaram; Catherine Hill; Christine Davies; Christopher S Johns; Jim M Wild; Robin Condliffe; David G Kiely
Journal:  Eur Respir J       Date:  2018-09-16       Impact factor: 33.795

View more
  12 in total

1.  Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.

Authors:  Danyan Su; Yanyun Huang; Dongli Liu; Yuqin Huang; Bingbing Ye; Suyuan Qin; Cheng Chen; Yusheng Pang
Journal:  Transl Pediatr       Date:  2022-05

2.  Long Noncoding RNA SOX2-OT Exacerbates Hypoxia-Induced Cardiomyocytes Injury by Regulating miR-27a-3p/TGFβR1 Axis.

Authors:  Guang Yang; Chunsheng Lin
Journal:  Cardiovasc Ther       Date:  2020-05-06       Impact factor: 3.023

Review 3.  Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.

Authors:  Damian Gajecki; Jakub Gawrys; Ewa Szahidewicz-Krupska; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-05-22       Impact factor: 6.543

4.  miR-1226-3p Promotes eNOS Expression of Pulmonary Arterial Endothelial Cells to Mitigate Hypertension in Rats via Targeting Profilin-1.

Authors:  Jie Jian; Liang Xia
Journal:  Biomed Res Int       Date:  2021-11-03       Impact factor: 3.411

5.  Expression and clinical significance of circular RNA hsa_circ_0003416 in pediatric pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Yanyun Huang; Danyan Su; Bingbing Ye; Yuqin Huang; Suyuan Qin; Cheng Chen; Yijue Zhao; Yusheng Pang
Journal:  J Clin Lab Anal       Date:  2022-02-15       Impact factor: 2.352

Review 6.  Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism.

Authors:  Qian Wang; Yuanyuan Sun; Qinhua Zhao; Wenhui Wu; Lan Wang; Yuqing Miao; Ping Yuan
Journal:  Animal Model Exp Med       Date:  2022-01-27

7.  Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.

Authors:  Xuefeng Lin; Liqin Zhang; Wei Zhang; Xinjun Lei; Qun Lu; Aiqun Ma
Journal:  Aging (Albany NY)       Date:  2022-03-06       Impact factor: 5.682

Review 8.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

9.  Hsa_circ_0002062 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells by Regulating the Hsa-miR-942-5p/CDK6 Signaling Pathway.

Authors:  Yali Wang; Xiaoming Tan; Yunjiang Wu; Sipei Cao; Yueyan Lou; Liyan Zhang; Feng Hu
Journal:  Front Genet       Date:  2021-07-12       Impact factor: 4.599

Review 10.  Circulating MicroRNAs for Diagnosis of Acute Pulmonary Embolism: Still a Long Way to Go.

Authors:  Matteo Sobrero; Fabrizio Montecucco; Federico Carbone
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.